Correlation Between Capital Income and PHARMACOLOG

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Capital Income and PHARMACOLOG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capital Income and PHARMACOLOG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capital Income Builder and PHARMACOLOG I UPPSALA, you can compare the effects of market volatilities on Capital Income and PHARMACOLOG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capital Income with a short position of PHARMACOLOG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capital Income and PHARMACOLOG.

Diversification Opportunities for Capital Income and PHARMACOLOG

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between Capital and PHARMACOLOG is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Capital Income Builder and PHARMACOLOG I UPPSALA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PHARMACOLOG I UPPSALA and Capital Income is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capital Income Builder are associated (or correlated) with PHARMACOLOG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PHARMACOLOG I UPPSALA has no effect on the direction of Capital Income i.e., Capital Income and PHARMACOLOG go up and down completely randomly.

Pair Corralation between Capital Income and PHARMACOLOG

Assuming the 90 days horizon Capital Income is expected to generate 19.12 times less return on investment than PHARMACOLOG. But when comparing it to its historical volatility, Capital Income Builder is 21.73 times less risky than PHARMACOLOG. It trades about 0.26 of its potential returns per unit of risk. PHARMACOLOG I UPPSALA is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  35.00  in PHARMACOLOG I UPPSALA on November 3, 2024 and sell it today you would earn a total of  20.00  from holding PHARMACOLOG I UPPSALA or generate 57.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Capital Income Builder  vs.  PHARMACOLOG I UPPSALA

 Performance 
       Timeline  
Capital Income Builder 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Capital Income Builder has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong fundamental drivers, Capital Income is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
PHARMACOLOG I UPPSALA 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PHARMACOLOG I UPPSALA are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, PHARMACOLOG reported solid returns over the last few months and may actually be approaching a breakup point.

Capital Income and PHARMACOLOG Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Capital Income and PHARMACOLOG

The main advantage of trading using opposite Capital Income and PHARMACOLOG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capital Income position performs unexpectedly, PHARMACOLOG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PHARMACOLOG will offset losses from the drop in PHARMACOLOG's long position.
The idea behind Capital Income Builder and PHARMACOLOG I UPPSALA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Money Managers
Screen money managers from public funds and ETFs managed around the world